CABA

Cabaletta Bio Inc
12.00
1.55 (14.83%)

Cabaletta Bio Inc. (CABA) Fundamentals

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers.
SHARE INFORMATION
Market Cap$ 324,045,807
Shares Outstanding29,140,810
Float27,675,878
Percent Float94.97%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.80
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions121
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months1,296,984
Institutional Holdings Percent53.2%
Institutional Sold Previous 3 Months2,956,712
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months366,000
Insider Holdings Percent4.1
Insider Sold Previous 3 Months-
Insider Shares Owned1,193,627
TRADING INFO
52 Week High$ 11.97
52 Week Low$ 0.59
52 Week High Change$ 291.55
21 Day Moving Average$ 9.799
21 Day Extended Moving Average$ 9.6923
50 Day Moving Average$ 7.0188
50 Day Extended Moving Average$ 7.5218
200 Day Moving Average$ 2.7349
200 Day Extended Moving Average$ 4.396
10 Day Average Volume840,132
20 Day Average Volume788,412
30 Day Average Volume910,651
50 Day Average Volume939,278
Alpha0.052995
Beta2.4532
Standard Deviation0.466117
R20.098535
7 Day Price Change$ 0.03
7 Day Percent Change0.27%
21 Day Price Change$ 0.55
21 Day Percent Change5.2%
30 Day Price Change$ 2.64
30 Day Percent Change31.13%
Month to Date Price Change$ 1.87
Month to Date Percent Change20.22%
Quarter to Date Price Change$ 1.87
Quarter to Date Percent Change20.22%
180 Day Price Change$ 9.80
180 Day Percent Change742.42%
200 Day Price Change$ 9.51
200 Day Percent Change590.68%
Year to Date Price Change$ 1.87
Year to Date Percent Change20.22%

Cabaletta Bio Inc. (CABA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio15.20
Leverage Ratio1.10
Quick Ratio14.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-6.60
Enterprise Value$ 256,509,517
Price to Sales0.00
Price to Free Cash-9.40
PE High Last 5 Years0.00
Price To Book4.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-47.75
Return on Equity-50.54
Return on Capital-51.09

Cabaletta Bio Inc. (CABA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOSteven Nichtberger
Emplyoees57
Last AuditUQ
CIK0001759138
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2929 Arch Street
Suite 600
Philadelphia, PA 19104
Websitehttps://www.cabalettabio.com
Facsimile-
Telephone+1 267 759-3100
Emailinvestors@cabalettabio.com


Your Recent History
NASDAQ
CABA
Cabaletta ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.